These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 8259844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S, Sato Y, Matsubara H, Adachi I, Yamaguchi K, Suzuki M, Suemasu K, Abe K.
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [Abstract] [Full Text] [Related]

  • 24. Symptomatic hypocalcemia following combined calcitonin and mithramycin therapy for hypercalcemia due to malignancy.
    Caro JF, Besarab A, Glennon JA.
    Cancer Treat Rep; 1978 Oct; 62(10):1561-3. PubMed ID: 152145
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.
    Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.
    Clin Lung Cancer; 2007 Jul; 8(7):434-5. PubMed ID: 17681097
    [Abstract] [Full Text] [Related]

  • 30. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I, Stachel D, Schön C, Bauer M, Haas RJ.
    Klin Padiatr; 2001 Jul; 213(1):30-4. PubMed ID: 11225473
    [Abstract] [Full Text] [Related]

  • 31. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
    Aasarød K, Lamvik J.
    Tidsskr Nor Laegeforen; 1989 Apr 30; 109(12):1293-6. PubMed ID: 2734758
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Medical treatment of hypercalcemia.
    Schaiff RA, Hall TG, Bar RS.
    Clin Pharm; 1989 Feb 30; 8(2):108-21. PubMed ID: 2521820
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Kozak S, Rizzoli R, Trechsel U, Fleisch H.
    Cancer Res; 1987 Dec 01; 47(23):6193-7. PubMed ID: 3677071
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
    Rosner MH, Dalkin AC.
    Clin J Am Soc Nephrol; 2012 Oct 01; 7(10):1722-9. PubMed ID: 22879438
    [Abstract] [Full Text] [Related]

  • 39. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC, Schfirin BS.
    Obstet Gynecol; 2006 Sep 01; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [Abstract] [Full Text] [Related]

  • 40. [The medical treatment of primary hyperparathyroidism].
    Lo Cascio V, Rossini M, Bertoldo F.
    Recenti Prog Med; 1993 Apr 01; 84(4):287-95. PubMed ID: 8488334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.